2m 2m 2m 2m 2m 2m 2m
JAGUAR HEALTH (JAGX)
NASDAQ
$0.93+$0.06 (+6.86%)
Price as of Aug 21, 2026 7:57 PM EDT- $4.3MMarket Cap
- -98.49%1-Year Change
- BiotechnologyIndustry
JAGUAR HEALTH (JAGX)
$0.93+$0.06 (+6.86%)
JAGX | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $0.87 | ||
Change | -$0.006 (-0.69%) | ||
Open | $0.87 | ||
High | $0.93 | ||
Low | $0.82 | ||
Previous Close | $0.87 | ||
Volume | 76,618 | ||
30-Day Average Volume | 169,725 | ||
1-Week Change | -5.29% | ||
1-Month Change | -31.15% | ||
1-Year Change | -98.49% | ||
3-Year Change | -100.00% | ||
5-Year Change | -100.00% | ||
Fundamentals | |||
Shares Outstanding | 4.9M | ||
Total Assets | $34.2M | ||
Market Cap | $4.3M | ||
Enterprise Value | $16.0M | ||
Period: QTR TTM FY | |||
Revenue | $43,000.00 | ||
Net Income | -$12.8M | ||
Free Cash Flow | -$5.3M | ||
EBIT | -$12.6M | ||
EBITDA | -$12.2M | ||
Net Working Capital | -$7.8M | ||
EPS | -$15.70 | ||
Enterprise Value/EBITDA | -1 | ||
Enterprise Value/Revenue | 373 | ||
P/B | 1 | ||
P/E | -0 | ||
PEG | 0 | ||
Price/Free Cash Flow | -1 | ||
Price/Operating Cash Flow | -1 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | 1 : 35 | ||
Last Split Date | 04/30/2026 | ||
Earnings & Revenue